Research

Cellular

Adverse effects of dual agonists are largely gastrointestinal and manageable.

Healthcare providers should inform patients about the manageable gastrointestinal side effects of dual agonists.

StrongSupportsmedium confidence
Adverse effects remain largely gastrointestinal and manageable through dose-escalation strategies.
Akter Sraboni et al. · Review of Medicine Surgery and Dentistry · 2026

Why this rating

The claim is based on evidence from clinical trials and observational research.

Source

Emerging Role of Dual Agonists in Metabolic Disease Management: Clinical Outcomes and Safety Considerations – A Review Study

Akter Sraboni et al. · Review of Medicine Surgery and Dentistry · 2026

DOI 10.64907/xkmf.v5.i1.rmsd.1

review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →